LIGAND PHARMACEUTICALS INCORPORATED Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) of $2.45 million as of 2012-03-31, per its 10-Q/A filed 2012-11-14.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValueCurrent · last filed 2012-11-14
- 2012-03-31: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $2.45M.
- 2011-12-31: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $6.88M.
- 2011-01-24: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $17.60M; Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) as first filed $19.20M.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) | Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2012-03-31 | $2.45M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $6.88M 10-Q/A · filed 2012-11-14 | |
| 2011-01-24 | $17.60M 10-Q/A · filed 2012-11-14 | $19.20M 10-Q · filed 2012-08-08 |